Bredicon Tablet

Desogestrel
75mg
RENATA LIMITED
Pack size
Dispensing mode
Source
Agent
Retail Price 200.00 NPR

Indications

Bredicon Tablet is used for: Oral contraception

Adult Dose

Oral Oral contraception Adult: 75 mcg daily when used alone. For monophasic combined oral contraceptives: Typically, 150 mcg daily; for triphasic combined oral contraceptives: 50-150 mcg daily.

Child Dose

Renal Dose

Administration

Contra Indications

Pregnancy, undiagnosed vaginal bleeding, severe arterial disease; liver adenoma, porphyria; after evacuation of hydatidiform mole; history of breast cancer.

Precautions

Heart disease, sex-steroid dependent cancer, past ectopic pregnancy, malabsorption syndromes, functional ovarian cysts, active liver disease, recurrent cholestatic jaundice, history of jaundice in pregnancy, history of CV or renal impairment, DM, asthma, epilepsy, migraine, depression and thromboembolism; lactation.

Pregnancy-Lactation

Interactions

Reduced efficacy with enzyme-inducing drugs; aminoglutethimide. May inhibit ciclosporin metabolism.

Adverse Effects

Side effects of Desogestrel : Menstrual irregularities; nausea, vomiting, headache, dizziness, breast discomfort, gynecomastia, depression, skin disorders, disturbance of appetite, wt changes, fluid retention, oedema, changes in libido, cholestatic jaundice, hair loss or hirsutism.

Mechanism of Action

Desogestrel is a progestogen structurally related to levonorgestrel that has been shown to reliably inhibit ovulation.

Note

Bredicon 75mg Tablet manufactured by RENATA LIMITED. Its generic name is Desogestrel. Bredicon is availble in Nepal. Farmaco Nepal drug index information on Bredicon Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Desogestrel :